Sarasin & Partners LLP Has $168.45 Million Holdings in Amgen Inc. (AMGN)

Amgen Inc. (NASDAQ:AMGN) was downgraded by investment analysts at Argus from a "buy" rating to a "hold" rating in a report issued on Wednesday, November 1st, Marketbeat.com reports. About 1.35M shares traded.

Amgen Inc., launched on October 31, 1986, is a biotechnology company. Greystone Managed Investments Inc acquired 22,561 shares as Canadian Natl Ry Co (CNI)'s stock rose 4.48%.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Finally, Baker Ellis Asset Management LLC bought a new stake in Amgen during the 3rd quarter worth about $108,000. Alethea Capital Management Llc owns 248,150 shares or 1.61% of their USA portfolio. Finally, Smithfield Trust Co. raised its stake in Amgen by 5.3% in the second quarter. The company's stock had a trading volume of 1,927,300 shares, compared to its average volume of 3,255,177. The Greystone Managed Investments Inc holds 880,139 shares with $71.31M value, up from 857,578 last quarter. Janus Henderson Group PLC now owns 3,699,351 shares of the medical research company's stock worth $637,139,000 after purchasing an additional 3,601,087 shares in the last quarter. Alpha Omega Wealth Management LLC increased its holdings in shares of Amgen by 19.0% in the first quarter. American Beacon Advisors Inc. purchased a new position in Amgen in the 1st quarter valued at approximately $106,000. This repurchase authorization permits the medical research company to buy shares of its stock through open market purchases. Company insiders own 0.19% of the company's stock.

AMGN has been the subject of several other reports.

Sarasin & Partners LLP trimmed its holdings in shares of Amgen Inc. On Thursday, October 26 the stock rating was maintained by RBC Capital Markets with "Hold". 557.32 million shares or 1.16% less from 563.88 million shares in 2017Q1 were reported. Cann reaffirmed a "buy" rating and issued a $203.00 price objective (up from $189.00) on shares of Amgen in a research note on Wednesday, July 26th. The firm has "Buy" rating by UBS given on Thursday, October 29. (NASDAQ:AMGN), 10 have Buy rating, 0 Sell and 12 Hold. Oppenheimer maintained the stock with "Buy" rating in Wednesday, July 12 report.

Almost half NHS doctors from EEA considering leaving the United Kingdom , survey reveals
BMA treasurer Dr Andrew Dearden said it was crucial the NHS doesn't lose "valuable experience and expertise" because of Brexit. We use cookies to give you the best experience on our website and bring you more relevant advertising.

"Penobscot Investment Management Company Inc". Renaissance Technologies LLC lifted its position in shares of Amgen by 40.9% in the second quarter. This defines the most likely future of the stock price of Amgen Inc. About shares traded. Delaware Enhanced Glbl. The company has a debt-to-equity ratio of 1.05, a quick ratio of 5.72 and a current ratio of 6.07. The firm has a market cap of $124,490.00, a PE ratio of 13.70, a P/E/G ratio of 2.50 and a beta of 1.37.

Amgen Inc. has a 1-year low of $139.02 and a 1-year high of $176.85.

Amgen (NASDAQ:AMGN) last posted its quarterly earnings data on Wednesday, October 25th. Amgen Inc. had 72 analyst reports since August 3, 2015 according to SRatingsIntel. Amgen had a net margin of 35.54% and a return on equity of 29.90%. The firm had revenue of $5.77 billion for the quarter, compared to analyst estimates of $5.75 billion. After $3.27 actual earnings per share reported by Amgen, Inc. for the previous quarter, Wall Street now forecasts -7.65% negative EPS growth.

Amgen declared that its Board of Directors has initiated a share repurchase plan on Wednesday, October 25th that allows the company to buyback $5.00 billion in shares. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 8th. Shareholders of record on Friday, November 17th will be paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.67%. Amgen's dividend payout ratio is presently 41.55%. Moreover, Saba Capital Management L.P. has 1.08% invested in the company for 1.05 million shares.

Lenoid meteor shower to occur in the UAE this weekend
Nasa recommends viewing the Leonids away from the radiant point to help the meteor streaks appear longer. November 17 and 18 would be the best time to watch the event, which will prevail throughout the month.

In other news, VP Annette Louise Such sold 3,000 shares of the business's stock in a transaction dated Tuesday, August 2nd. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

In related news, Director Carbonnel Francois De sold 4,000 shares of the company's stock in a transaction dated Wednesday, November 8th. Zurcher Kantonalbank Zurich Cantonalbank sold 75,163 shares as Morgan Stanley (MS)'s stock declined 9.43%. The disclosure for this sale can be found here.

In the market the company is trading down by 0.30% since yesterday's close of 172.35.

The ROA of Amgen Inc.is now valued at 10.40% indicating how profitable the company is in regards to its total assets. The Company discovers, develops, manufactures and delivers various human therapeutics.

Dudas sobre Rusia acompañan a Trump en su gira por Asia
Trump realizó estas declaraciones poco antes de partir hacia Filipinas, la última parada de su gira por cinco países asiáticos. Pero el mandatario dijo también que cree a su homólogo ruso, Vladimir Putin, cuando dice que Moscú no hizo tal cosa.

Últimas notícias